Wockhardt to exit residual US generics business for “commercial reasons”
[ad_1] Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons. Over two years ago, the Mumbai-based drugmaker had
[ad_1] Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons. Over two years ago, the Mumbai-based drugmaker had